Sanjay Rathod

Associate Director @Novasenta

Pittsburgh, PA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jun 2024 — Present

Associate Director @Novasenta

View department →

Pittsburgh, PA, US

Sanjay has played a pivotal role within the Discovery/Assay Development team in developing robust assays for NST0036 and other targets mAb screening, NST-3602 lead selection and MOA characterization. He has also led multiple IND supporting activities and has drafted numerous NST-3602 study reports that support the IND to move closer to our goal of bringing NST-3602 to patients in the clinic early next year.Patent: WO 2024/229461 A2 for anti-CD161 antibodies and method of use thereof (2024).

EDUCATION

2009 — 2016

National Institute Of Virology

Doctor of Philosophy (PhD), Biotechnology

N/A

University of Pittsburgh

Postdoctoral Associate, Immunology

SKILLS

ImmunologyAssay DevelopmentT Cells Differentiation(Th1, Th2, Th17 and Treg)Sds-PageCell CulturePolymerase Chain Reaction (Pcr)Treg Cells BiologyDna ExtractionWestern BlottingLife SciencesCellReverse Transcription Polymerase Chain Reaction (Rt-Pcr)Ror-GammaMolecular BiologyFluorescence MicroscopyBiotechnologyProtein PurificationPcrImmunetherapyImmune CheckpointsMicrobiologyReal-Time Polymerase Chain Reaction (Qpcr)ElisaFlow CytometryCell Biology

ABOUT SANJAY RATHOD

I\'ve dedicated myself to research to improve the lives of cancer patients by developing the next generation of cancer immunotherapies. I regularly connect with colleagues from many functional areas, and I am continually broadening my views.Every day, I like what I do!Research Interests:Immunology/Immuno-oncology/Drug Development

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.